Ranked GEO Datasets

Gene snapshot Projects Saved searches CSV Markdown

Collections related to this search

Explore premium collections with reusable study, cohort and sample curation. The matching scope is stated for each collection. Organism, tissue, comparison and sample requirements still need review; collection availability does not affect dataset ranking.

Rheumatoid Arthritis Synovium/Blood Expression Collection

Disease scope matches your disease term.

Public rheumatoid arthritis expression datasets focused on synovium and blood contexts.

Preview fixture · Version v0.1-preview

Study inventory
3 datasets
Reported sample inventory
275 samples
Updated
2026-06-22
Disease
Rheumatoid arthritis
Organisms
Homo sapiens
Technologies
microarray, bulk RNA-seq
Tissues
synovium, whole blood, PBMC
Comparisons
RA vs healthy control, RA synovium vs control tissue, active disease vs remission
Query overlap with this collection version
DimensionYour queryCollection scopeComparison
Disease Rheumatoid arthritisRheumatoid arthritis MATCH

Declared collection scope includes this requested dimension; question-specific sample eligibility still needs review.

Specimen synovium, whole blood, PBMC NOT_REQUESTED

No explicit query requirement was supplied for this dimension.

Organism Homo sapiens NOT_REQUESTED

No explicit query requirement was supplied for this dimension.

Comparison RA vs healthy control, RA synovium vs control tissue, active disease vs remission NOT_REQUESTED

No explicit query requirement was supplied for this dimension.

Full access adds reusable curated cohort structure, sample decisions and provenance. Review the content status above before treating a release as professionally approved. Ordinary Search results remain available below.

Preview collection

Counts describe the collection inventory, not final eligible samples or independent subjects. Preview fixtures are illustrative; review-pending releases are not professionally approved.

Public previews are free. Full collections and exports require access approval. Online checkout is not available.

15 shown of 136 matching datasets Comparison Tumor vs normal Tissue/sample context Patient tissue Organism Any organism Assay Any assay Ranking defaults Modified 6 user changes 1 active filters Page 2 of 10 · showing 16-30
Treatment requirements Optional See what each comparison arm must satisfy — Unrestricted

Comparison: Tumor vs normal

Case arm

Your requirement
Treatment agent

Comparator

From comparison

Determined by comparison

For treatment vs control, use a named agent, an explicit collection window and an exposed or unexposed state. The comparator needs the opposite reported exposure state for the same agent, target and window.

Other comparisons keep their own normal or healthy comparator requirements. This treatment restriction is not copied to them.

Collection, target and matching

Named agent if supplied; otherwise all interventions.

Scope & matching · additional options

Missing metadata never proves no exposure.

Evidence and comparison rules

Exact results require an eligible sample subset and reported independent subjects in both arms.

“No exposure” applies only to the selected agent, target and time window. No exposure to a new agent before collection does not rule out earlier therapy.

A broader treatment history requires separate, explicit evidence and may be unavailable. All prior therapy requires a through-collection window.

Planned exposure does not establish that treatment occurred. Treatment vs control requires an exposed or unexposed state, a named agent and an explicit collection window.

Organism and specimen requirements apply to both arms. For treatment vs control, disease requirements also apply to both arms.

Genotype requirements Optional Define a requirement, then assign it to samples — Unrestricted
Genotype assignment and variant
Specific protein variant · optional

Leave blank for a gene-level requirement. A variant restriction applies to every selected arm.

Genotype describes sampled material. Confirmed evidence must come from the same samples as your other requirements.

Use with human bulk RNA-seq or expression microarray.

Evidence and comparison rules

Select Homo sapiens and a supported assay in the search filters.

Missing genotype does not establish wild type. Both comparison arms still need eligible, independent samples.

A subject's carrier status does not establish the sampled tumor's genotype or disease.

Ranking filters

Fine-tune ranking behavior without changing the search criteria above.

Clear filters Ranking defaults Relax defaults

Showing one page of matching results. Use next/previous for browsing, or CSV/Markdown export for the full matching set.

Strict results

These datasets meet every active search criterion.

Organization: Newcastle University

Case rheumatoid arthritis Control control
Disease/model vs control Biofluid
Rationale for Tumor vs normal

Dataset does not meet the current suitability threshold.

  • Downgraded for tissue search because it is a biofluid cohort.
  • Downgraded assay: microarray cohorts are separated from the RNA-seq intent.
  • Interpreted disease metadata: Rheumatoid arthritis.
  • Processed data is available for downstream review.
  • External evidence: PubMed links 1 publication; 1 DOI available: PMID 31945409.
info Microarray expression context was detected; compare separately from RNA-seq cohorts. warning This record is a third-party integration or reanalysis of public datasets. The GEO sample count may describe deposited atlas records rather than one independent clinical cohort; verify source-study provenance before analysis. warning Microarray datasets are downgraded in the patient-tissue tumor-normal intent unless secondary assays are explicitly enabled.

Organization: Newcastle University

Case rheumatoid arthritis Control control
Disease/model vs control Biofluid
Rationale for Tumor vs normal

Dataset does not meet the current suitability threshold.

  • Downgraded for tissue search because it is a biofluid cohort.
  • Downgraded assay: microarray cohorts are separated from the RNA-seq intent.
  • Interpreted disease metadata: Lupus erythematosus, Rheumatoid arthritis.
  • Processed data is available for downstream review.
  • External evidence: PubMed links 1 publication; 1 DOI available: PMID 31945409.
info Microarray expression context was detected; compare separately from RNA-seq cohorts. warning This record is a third-party integration or reanalysis of public datasets. The GEO sample count may describe deposited atlas records rather than one independent clinical cohort; verify source-study provenance before analysis. warning Microarray datasets are downgraded in the patient-tissue tumor-normal intent unless secondary assays are explicitly enabled.

Organization: Ehime University

Case rheumatoid arthritis Control healthy control
Disease/model vs control Tissue
Rationale for Tumor vs normal

Dataset does not meet the current suitability threshold.

  • Prioritized assay: bulk RNA-seq is the active assay expectation.
  • Interpreted disease metadata: Rheumatoid arthritis.
  • Processed data is available for downstream review.
  • External evidence: PubMed links 1 publication; 1 DOI available: PMID 33256735.
critical Dataset organism does not match the human patient-tissue tumor-normal intent.

Organization: Janssen R&D LLC

Case treated Control untreated
Treatment vs control Unclear specimen/source
Rationale for Tumor vs normal

Dataset does not meet the current suitability threshold.

  • Downgraded for tissue search because it is a treatment/control experiment.
  • Downgraded for tissue search because study design or specimen source is unclear.
  • Prioritized assay: bulk RNA-seq is the active assay expectation.
  • Interpreted disease metadata: Rheumatoid arthritis.
  • Processed data is available for downstream review.
  • External evidence: PubMed links 1 publication; 1 DOI available: PMID 33288543.
warning Patient-tissue tumor-normal intent requires tissue or biopsy source clarity.

Organization: Kobe University Graduate School of Medicine

Case rheumatoid arthritis Control control
Treatment vs control Tissue
Rationale for Tumor vs normal

Dataset does not meet the current suitability threshold.

  • Downgraded for tissue search because it is a treatment/control experiment.
  • Downgraded assay: microarray cohorts are separated from the RNA-seq intent.
  • Interpreted disease metadata: Rheumatoid arthritis.
  • Processed data is available for downstream review.
  • External evidence: PubMed links 1 publication; 1 DOI available: PMID 34345282.
info Treated samples may need review depending on the comparison. info Microarray expression context was detected; compare separately from RNA-seq cohorts. warning Microarray datasets are downgraded in the patient-tissue tumor-normal intent unless secondary assays are explicitly enabled.

Organization: CEA IG

Case rheumatoid arthritis Control control
Disease/model vs control Biofluid
Rationale for Tumor vs normal

Dataset does not meet the current suitability threshold.

  • Downgraded for tissue search because it is a biofluid cohort.
  • Downgraded assay: microarray cohorts are separated from the RNA-seq intent.
  • Interpreted disease metadata: Rheumatoid arthritis.
  • Processed data is available for downstream review.
  • External evidence: PubMed links 9 publications; 9 DOIs available: PMID 19710928, PMID 28818099, PMID 35589811, PMID 37595490, PMID 39466354.
info Microarray expression context was detected; compare separately from RNA-seq cohorts. warning Microarray datasets are downgraded in the patient-tissue tumor-normal intent unless secondary assays are explicitly enabled.

Organization: Universidad de Zaragoza

Case mixed disease cohort Control control
Disease/model vs control Mixed specimen/source
Rationale for Tumor vs normal

Dataset does not meet the current suitability threshold.

  • Downgraded for tissue search because specimen/source classes are mixed.
  • Prioritized assay: bulk RNA-seq is the active assay expectation.
  • Interpreted disease metadata: Rheumatoid arthritis.
  • Processed data is available for downstream review.
  • External evidence: PubMed links 2 publications; 2 DOIs available: PMID 36194479, PMID 37916875.
warning Multiple disease or phenotype arms were detected. The displayed grouping summarizes the full dataset; select the requested disease-specific contrast before analysis. warning Patient-tissue tumor-normal intent requires tissue or biopsy source clarity.

Organization: Department of Rheumatology and Immunology, The First Affiliated Hospital, Sun Yat-sen University

Case rheumatoid arthritis Control control
Disease/model vs control Tissue
Rationale for Tumor vs normal

Dataset does not meet the current suitability threshold.

  • Downgraded assay: microarray cohorts are separated from the RNA-seq intent.
  • Interpreted disease metadata: Rheumatoid arthritis.
  • Processed data is available for downstream review.
  • External evidence: PubMed links 2 publications; 2 DOIs available: PMID 36542956, PMID 39433011.
warning Secondary RNA assay context such as small RNA, miRNA, circRNA, or non-coding RNA was detected. info Microarray expression context was detected; compare separately from RNA-seq cohorts. warning Microarray datasets are downgraded in the patient-tissue tumor-normal intent unless secondary assays are explicitly enabled.

Organization: Emory University

Case treated Control untreated
Treatment vs control Biofluid
Rationale for Tumor vs normal

Dataset does not meet the current suitability threshold.

  • Downgraded for tissue search because it is a biofluid cohort.
  • Downgraded for tissue search because it is a treatment/control experiment.
  • Prioritized assay: bulk RNA-seq is the active assay expectation.
  • Interpreted disease metadata: Rheumatoid arthritis.
  • Processed data is available for downstream review.
  • External evidence: PubMed links 1 publication; 1 DOI available: PMID 35002734.

No warnings

Organization: Jiangxi Chinese Medical University

Case rheumatoid arthritis Control healthy control
Patient biofluid vs healthy control Biofluid
Rationale for Tumor vs normal

Dataset does not meet the current suitability threshold.

  • Downgraded for tissue search because it is a biofluid cohort.
  • Downgraded assay: microarray cohorts are separated from the RNA-seq intent.
  • Interpreted disease metadata: Lupus erythematosus, Rheumatoid arthritis, Systemic lupus erythematosus.
  • Processed data is available for downstream review.
  • External evidence: PubMed links 3 publications; 3 DOIs available: PMID 35379246, PMID 40778323, PMID 42246038.
warning Secondary RNA assay context such as small RNA, miRNA, circRNA, or non-coding RNA was detected. info Microarray expression context was detected; compare separately from RNA-seq cohorts. warning Microarray datasets are downgraded in the patient-tissue tumor-normal intent unless secondary assays are explicitly enabled.

Organization: Charité University Hospital

Case rheumatoid arthritis Control normal tissue
Disease/model vs control Unclear specimen/source
Rationale for Tumor vs normal

Dataset does not meet the current suitability threshold.

  • Downgraded for tissue search because study design or specimen source is unclear.
  • Downgraded assay: microarray cohorts are separated from the RNA-seq intent.
  • Interpreted disease metadata: Rheumatoid arthritis.
  • Processed data is available for downstream review.
  • External evidence: Expression Atlas curated experiment link is available.
  • External evidence: PubMed links 21 publications; 21 DOIs available: PMID 20858714, PMID 36389761, PMID 36459007, PMID 36468029, PMID 36681837.
info Microarray expression context was detected; compare separately from RNA-seq cohorts. warning Microarray datasets are downgraded in the patient-tissue tumor-normal intent unless secondary assays are explicitly enabled. warning Patient-tissue tumor-normal intent requires tissue or biopsy source clarity.

Organization: Medical Univrsity of Vienna

Case knockdown Control genetic control
Treatment vs control Tissue
Rationale for Tumor vs normal

Dataset does not meet the current suitability threshold.

  • Downgraded for tissue search because it is a treatment/control experiment.
  • Prioritized assay: bulk RNA-seq is the active assay expectation.
  • Interpreted disease metadata: Rheumatoid arthritis.
  • Processed data is available for downstream review.
  • External evidence: PubMed links 1 publication; 1 DOI available: PMID 35258553.

No warnings

Organization: Kobe University Graduate School of Medicine

Case rheumatoid arthritis Control control
Treatment vs control Unclear specimen/source
Rationale for Tumor vs normal

Dataset does not meet the current suitability threshold.

  • Downgraded for tissue search because it is a treatment/control experiment.
  • Downgraded for tissue search because study design or specimen source is unclear.
  • Downgraded assay: microarray cohorts are separated from the RNA-seq intent.
  • Interpreted disease metadata: Rheumatoid arthritis.
  • Processed data is available for downstream review.
  • External evidence: PubMed links 1 publication; 1 DOI available: PMID 38401037.
info Treated samples may need review depending on the comparison. info Microarray expression context was detected; compare separately from RNA-seq cohorts. warning Microarray datasets are downgraded in the patient-tissue tumor-normal intent unless secondary assays are explicitly enabled. warning Patient-tissue tumor-normal intent requires tissue or biopsy source clarity.

Organization: Sanofi-Aventis Deutschland GmbH

Case treated Control untreated
Treatment vs control Biofluid
Rationale for Tumor vs normal

Dataset does not meet the current suitability threshold.

  • Downgraded for tissue search because it is a biofluid cohort.
  • Downgraded for tissue search because it is a treatment/control experiment.
  • Prioritized assay: bulk RNA-seq is the active assay expectation.
  • Interpreted disease metadata: Rheumatoid arthritis.
  • Processed data is available for downstream review.
info Treated samples may need review depending on the comparison. info Treated and untreated samples are both present.

Organization: Charité University Hospital

Case rheumatoid arthritis Control normal tissue
Disease/model vs control Unclear specimen/source
Rationale for Tumor vs normal

Dataset does not meet the current suitability threshold.

  • Downgraded for tissue search because study design or specimen source is unclear.
  • Downgraded assay: microarray cohorts are separated from the RNA-seq intent.
  • Interpreted disease metadata: Rheumatoid arthritis.
  • Processed data is available for downstream review.
  • External evidence: PubMed links 3 publications; 3 DOIs available: PMID 20858714, PMID 24238402, PMID 42127012.
info Microarray expression context was detected; compare separately from RNA-seq cohorts. warning Microarray datasets are downgraded in the patient-tissue tumor-normal intent unless secondary assays are explicitly enabled. warning Patient-tissue tumor-normal intent requires tissue or biopsy source clarity.